Abstract
Maternal chemoprophylaxis with intra-partum antibiotics (IPA), has been increasingly enouraged over the past several years in an attempt to reduce the incidence of GBS infections. We wondered what impact these exhortations had on the incidence, morbidity, and mortality of GBS infections in our institution.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
